Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation.

Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation.

Item

http://www.wikidata.org/entity/Q34427584

Q34427584

about

The European Paediatric Mycology Network (EPMyN): Towards a Better Understanding and Management of Fungal Infections in Children Prevention of invasive fungal infections in immunocompromised patients: the role of delayed-release posaconazole Antifungal Prophylaxis in Immunocompromised Patients Galactomannan, β-D-Glucan, and Polymerase Chain Reaction-Based Assays for the Diagnosis of Invasive Fungal Disease in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.Strategies for reducing the treatment-related physical burden of childhood acute myeloid leukaemia - a review.Systemic antifungal prescribing in neonates and children: outcomes from the Antibiotic Resistance and Prescribing in European Children (ARPEC) Study Serum galactomannan index for early prediction of mortality in immunocompromised children with invasive pulmonary aspergillosis.β-D-Glucan Screening for Detection of Invasive Fungal Disease in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.Clinical Features and Prognosis of Invasive Pulmonary Aspergillosis in Korean Children with Hematologic/Oncologic Diseases Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia.Prevalence of the reversed halo sign in neutropenic patients compared with non-neutropenic patients: Data from a single-centre study involving 27 patients with pulmonary mucormycosis (2003-2016).Primary antifungal prophylaxis during curative-intent therapy for acute myeloid leukemia.Infectious complications in children with acute myeloid leukemia: decreased mortality in multicenter trial AML-BFM 2004.Candida Associated Bloodstream Infections in Pediatric Hematology Patients: A Single Center Experience.Pharmacodynamics of Voriconazole in Children: Further Steps along the Path to True Individualized Therapy.Prognostic Factors on the Graft-versus-Host Disease-Free and Relapse-Free Survival after Adult Allogeneic Hematopoietic Stem Cell Transplantation.Antifungal prophylaxis of patients undergoing allogenetic hematopoietic stem cell transplantation in China: a multicenter prospective observational study.Prospective Biomarker Screening for Diagnosis of Invasive Aspergillosis in High-Risk Pediatric Patients.Invasive candidiasis and candidaemia in neonates and children: update on current guidelines.Anti-infective prophylaxis in pediatric patients with acute myeloid leukemia.Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2014.Clinical pharmacology of antifungal agents to overcome drug resistance in pediatric patients.Therapeutic strategies for invasive fungal infections in neonatal and pediatric patients: an update.Infectious complications in children with acute lymphoblastic leukemia treated in low-middle-income countries.Our 2015 approach to invasive pulmonary aspergillosis.Impact of special patient populations on the pharmacokinetics of echinocandins.Performance of 1,3-β-D-glucan for diagnosing invasive fungal diseases in children.Influence of CYP2C19 Genotypes on the Occurrence of Adverse Drug Reactions of Voriconazole among Hematological Patients after Allo-HSCT.Biomarker-based diagnostic work-up of invasive pulmonary aspergillosis in immunocompromised paediatric patients--is Aspergillus PCR appropriate?Therapeutic drug monitoring in neonates.Current strategies against invasive fungal infections in patients with aplastic anemia, strong power and weak weapon, a case report and review of literature Pharmacokinetic considerations in treating invasive pediatric fungal infections.Lichtheimia Infection in a Lymphoma Patient: Case Report and a Brief Review of the Available Diagnostic Tools.Critical review of current clinical practice guidelines for antifungal therapy in paediatric haematology and oncology.Epidemiology of invasive fungal diseases in children with solid tumours undergoing autologous haematopoietic stem cell transplantation: a 10-year experience in a tertiary Italian centre.Use of Fungal Diagnostics and Therapy in Pediatric Cancer Patients in Resource-Limited Settings.The combination of bortezomib with chemotherapy to treat relapsed/refractory acute lymphoblastic leukaemia of childhood.Second line azacitidine for elderly or infirmed patients with acute myeloid leukemia (AML) not eligible for allogeneic hematopoietic cell transplantation-a retrospective national multicenter study.Liposomal amphotericin B (AmBisome®) at beginning of its third decade of clinical use.A review of infectious complications after haploidentical hematopoietic stem cell transplantations.

P2860

Q26749001-13774A8D-41F5-4296-B4AD-421340E0E9D0 Q26782472-504E2771-2E25-405E-A741-8A88D3F127F1 Q28074168-EA61461A-CF94-4F8C-B9C8-2DB027F83D48 Q30244009-1A80E585-E45E-46BB-B62E-8AC81093DEA8 Q30244244-FA94ACE7-366F-4D46-9FA0-68722529C32E Q35105787-F6C8F78D-FE21-4341-873B-BBE256D1C15A Q35689788-747C95B8-E1D0-47B3-9E56-ED3B224A0E7E Q35868758-1FFCEB70-65FB-4F8F-9C8A-E78858DE95F7 Q35905124-03B6935E-776C-4A21-9A33-E4400A1DCAA1 Q36053792-F536EDF1-BFAC-4BCE-9291-C3088816A5E3 Q36353240-1A1ACED7-0900-47EF-99F7-324AACBFC850 Q36406975-9438F915-9524-4FD5-AEF5-634468AC61A5 Q36548058-CBB80CBB-30FB-411E-897E-1B01E4F9D0AB Q36630796-B987237F-52DD-450C-B486-B06B8B0F606A Q36730105-524AA469-1C9E-4C2E-9811-BC2AFDECE378 Q36792818-1CD0D247-9218-4272-8DB0-8AE5EDCF6D8C Q37280740-3ED07DEE-CDD2-4004-B484-F113BCC0B15C Q37581839-E1D4482F-07EB-4DB3-B0CA-C6FFFB5A7B41 Q38263282-0A310900-32C1-4AAF-ADEF-781C8960602A Q38264086-DCBD7A91-C62D-4807-AB26-1E47E5ED37CF Q38284455-010A7BB6-CA98-4BCF-B44D-A664A756DCE9 Q38314467-00CF3F73-19BD-445F-9252-3EE22D7E66BB Q38353420-9EB6B894-A6C8-4D06-A622-D7EAD15DFE5F Q38388198-022E2397-E979-4323-92D6-65F7BDE6CD16 Q38391049-07FE414A-541B-43E6-BDC2-D267E734CE9F Q38462784-E06E09E7-133B-4A69-832F-08DECF7D1973 Q38611989-87C3E1EA-2379-4298-9496-E29C846791C1 Q38690098-1D79851A-A9DF-40B7-ACB4-CF090FFCCA51 Q38693242-968A8698-8405-4C0F-BF90-9341C519E896 Q38709104-61DB3DD7-C497-40CC-B2BF-53BB54D3E46C Q38798744-189D15B7-FD58-4E83-9998-7EF4038A7B98 Q38816614-B3A3F65D-92D6-417A-ADAD-A3194B5567A7 Q38817878-AA2B5293-E168-4426-ACFD-9BEE03F972AB Q38822532-5928B229-F37B-43CF-B92A-EDA3F32D8351 Q38827118-E5CE86FA-595E-40AE-9206-057A7B7C1007 Q38965488-562170BE-C295-43F5-ABD0-74AC69094D30 Q39002810-C6579E37-D523-46CA-89F6-C05F27B1F242 Q39036999-3CA0E0A9-3B49-4A0A-B3C9-45D11CB8E9F1 Q39196802-F75DBA99-873E-4764-97AF-FB47BED88CD9 Q39247468-85F4623C-4315-48DC-91B2-92B755B2474A

P2860

Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation.

Item

http://www.wikidata.org/entity/Q34427584

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu